Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Switch from oral selegiline to Zelapar in Parkinson's disease
NCT00640159Phase 4Completed
- Sponsor
- Baylor College of Medicine
- Start
- Jan 2007
- Primary completion
- Jun 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of selegiline in Parkinson's disease (PD), sponsored by Baylor College of Medicine. Started Jan 2007; status: completed.
02
Drugs
selegiline
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT00640159.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00640159.